Literature DB >> 24423895

Should journals stop publishing research funded by the drug industry?

Richard Smith1, Peter C Gøtzsche, Trish Groves.   

Abstract

Mesh:

Year:  2014        PMID: 24423895     DOI: 10.1136/bmj.g171

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.

Authors:  Nitin Roper; Deborah Korenstein
Journal:  J Gen Intern Med       Date:  2015-04-02       Impact factor: 5.128

2.  Conflict of interest disclosure in biomedical research: A review of current practices, biases, and the role of public registries in improving transparency.

Authors:  Adam G Dunn; Enrico Coiera; Kenneth D Mandl; Florence T Bourgeois
Journal:  Res Integr Peer Rev       Date:  2016-05-03

3.  Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.

Authors:  Jean-David Zeitoun; Joseph S Ross; Ignacio Atal; Alexandre Vivot; Nicholas S Downing; Gabriel Baron; Philippe Ravaud
Journal:  BMJ Open       Date:  2017-12-21       Impact factor: 2.692

4.  Marketing trials, marketing tricks - how to spot them and how to stop them.

Authors:  Alastair Matheson
Journal:  Trials       Date:  2017-03-08       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.